Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition

Schneeweis, C., Hassan, Z., Ascherl, K., Wirth, M., Koutsouli, S., Orben, F., Krauss, L., Schneider, C., Ollinger, R., Kramer, O. H., Rad, R., Reichert, M., Robles, M. S., Saur, D., and Schneider, G. (2022). Cancer Commun (Lond) 42, 360-364. doi: 10.1002/cac2.12280